SAN DIEGO, March 2, 2025 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025 )
Also on site :
- Heartbreaking letters Camp Mystic children wrote to their family arrive days after they died in Texas floods
- Watch- Shubman Gill reacts as Ravindra Jadeja teases him in front of Sara Tendulkar
- ‘I knew I would prevail’: Palestinian activist Mahmoud Khalil talks to CNN about his months in ICE detention